Michael J. Thirman to Antimetabolites, Antineoplastic
This is a "connection" page, showing publications Michael J. Thirman has written about Antimetabolites, Antineoplastic.
Connection Strength
0.152
-
Efficacy of single-agent decitabine in relapsed and refractory acute myeloid leukemia. Leuk Lymphoma. 2017 09; 58(9):1-7.
Score: 0.127
-
A novel clofarabine bridge strategy facilitates allogeneic transplantation in patients with relapsed/refractory leukemia and high-risk myelodysplastic syndromes. Bone Marrow Transplant. 2013 Nov; 48(11):1437-43.
Score: 0.025